With 21.07 million shares changed hands, the volume of the stock remained lighter than its average volume of 23.32 million shares. During the session, the Pharmaceutical Retailers company that operates in wider Healthcare sector, reached to the highest price of $9.97 whereas the lowest price it dropped to was $9.41. The 52-week range on WBA shows that it touched its highest point at $25.87 and its lowest point at $8.08 during that stretch. It currently has a 1-year price target of $9.94. With its current market cap of 8.45 billion, WBA has annualized dividend of $1.00 while the current yield stands at 10.56%. Beta for the stock currently stands at 0.61.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of WBA was down-trending over the past week, with a drop of -1.56%, but this was up by 8.35% over a month. Three-month performance surged to 8.60% while six-month performance fell -12.48%. The stock lost -60.96% in the past year, while it has gained 1.50% so far this year. A look at the trailing 12-month EPS for WBA yields -10.01 with Next year EPS estimates of 1.43. For the next quarter, that number is 0.38. This implies an EPS growth rate of -47.06% for this year and -6.48% for next year.
Float and Shares Shorts:
At present, 864.00 million WBA shares are outstanding with a float of 709.12 million shares on hand for trading. On 2024-12-13, short shares totaled 96.53 million, which was 1118.0 higher than short shares on 1731628800. In addition to Mr. Stefano Pessina as the firm’s Executive Chairman of the Board, Mr. Timothy C. Wentworth serves as its CEO & Director.
Institutional Ownership:
Through their ownership of 0.61774 of WBA’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-08-31, WBA reported revenue of $37547000000.0 and operating income of -$695000000.0. The EBITDA in the recently reported quarter was $87000000.0 and diluted EPS was $nan.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for WBA since 11 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 1 suggest SELL ratings. Of the remaining analysts, 6 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With WBA analysts setting a high price target of 20.0 and a low target of 7.0, the average target price over the next 12 months is 10.35714. Based on these targets, WBA could surge 111.19% to reach the target high and fall by -26.08% to reach the target low. Reaching the average price target will result in a growth of 9.37% from current levels.
Analysts have provided yearly estimates in a range of $2.89502 being high and $2.80518 being low. For WBA, this leads to a yearly average estimate of $2.84511.
